SYNGENE INTERNATIONAL LTD (SYNGENE) financials

SYNGENE INTERNATIONAL LTD (SYNGENE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations.[1]

Market Cap: ₹15,551Cr.
Current Price: ₹385
Stock P/E: 51.8
ROE: 7.71%
ROCE: 9.91%
Book Value: ₹117
Dividend Yield: 0.33%
52W High / Low: ₹679/344

In Jun 2026, SYNGENE INTERNATIONAL LTD (SYNGENE) reported sales ₹663.00 Cr and net profit ₹-2.10 Cr.

Annual TTM: sales ₹3,288 Cr, net profit ₹229 Cr.

Shareholding: Promoters 52.59% (Sep 2026), FIIs 10.13% (Sep 2026), DIIs 29.31% (Sep 2026), Public 7.55% (Sep 2026), Others 0.41% (Sep 2026).

SYNGENE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	821.30	877.10	948.40	799.30	830.10	834.40	960.00	663.00
Expenses	612.70	626.30	638.40	631.20	652.60	649.70	675.70	584.60
Operating Profit	208.60	250.80	310.00	168.10	177.50	184.70	284.30	78.40
OPM %	25.40%	28.59%	32.69%	21.03%	21.38%	22.14%	29.61%	11.83%
Other Income	16.40	18.00	18.40	16.60	14.20	-51.30	14.20	11.30
Interest	7.00	6.70	10.10	5.90	7.40	6.20	6.50	4.10
Depreciation	93.70	92.30	89.60	94.60	100.10	97.10	95.30	95.60
Profit before tax	124.30	169.80	228.70	84.20	84.20	30.10	196.70	-10.00
Tax %	22.28%	27.50%	23.74%	12.11%	21.38%	45.18%	24.66%	-79.00%
Net Profit	96.60	123.10	174.40	74.00	66.20	16.50	148.20	-2.10
EPS in Rs	2.40	3.06	4.33	1.84	1.64	0.41	3.68	-0.05
Raw PDF	—	—	—	—	—	—	—	—

SYNGENE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2,012	2,179	2,601	3,194	3,203	3,373	3,424	3,288
Expenses	1,395	1,504	1,861	2,252	2,322	2,453	2,606	2,563
Operating Profit	617	676	741	942	881	920	817	725
OPM %	31%	31%	28%	29%	28%	27%	24%	22%
Other Income	153	94	75	63	74	100	-9	-12
Interest	35	28	24	45	30	31	26	24
Depreciation	219	274	310	359	369	367	387	388
Profit before tax	516	467	482	601	557	622	395	301
Tax %	20%	14%	18%	21%	16%	25%	23%	—
Net Profit	412	404	394	473	466	468	305	229
EPS in Rs	10.29	10.09	9.83	11.78	11.60	11.63	7.57	5.68
Dividend Payout %	0%	0%	10%	11%	11%	11%	17%	—

SYNGENE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	200	400	400	401	401	402	402	403
Reserves	1,767	1,774	2,418	2,891	3,218	3,790	4,236	4,301
Borrowings	813	773	893	1,022	639	332	306	201
Other Liabilities	922	1,215	1,166	1,247	1,590	1,310	1,462	1,658
Total Liabilities	3,702	4,162	4,878	5,561	5,848	5,834	6,407	6,563
Fixed Assets	1,377	2,020	2,201	2,393	2,260	2,318	2,241	2,487
CWIP	274	234	237	346	126	760	880	541
Investments	716	777	702	1,034	941	928	1,468	1,564
Other Assets	1,336	1,132	1,737	1,787	2,521	1,829	1,818	1,971
Total Assets	3,702	4,162	4,878	5,561	5,848	5,834	6,407	6,563

SYNGENE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	630	677	698	582	838	913	1,114	831
Cash from Investing Activity	-646	-424	-629	-611	-685	-383	-810	-766
Cash from Financing Activity	-72	-226	58	-31	-340	-536	-136	-178
Net Cash Flow	-88	28	127	-60	-187	-6	167	-113
Free Cash Flow	46	34	252	107	305	568	736	544
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	135%	127%	116%	93%	103%	115%	132%	107%

SYNGENE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	52.74%	52.74%	52.68%	52.68%	52.68%	52.68%	52.59%	52.59%
FIIs	20.65%	19.47%	16.51%	16.31%	14.96%	13.91%	11.82%	10.13%
DIIs	19.52%	21.50%	24.05%	24.62%	25.83%	26.44%	28.01%	29.31%
Public	6.79%	5.99%	6.45%	6.08%	6.22%	6.69%	7.15%	7.55%
Others	0.29%	0.29%	0.31%	0.30%	0.29%	0.29%	0.43%	0.41%
No. of Shareholders	1,28,806	1,25,090	1,42,310	1,36,061	1,31,750	1,35,605	1,42,277	1,34,008

SYNGENE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	68	72	57	71	55	49	51	46
Inventory Days	30	18	41	87	141	95	62	60
Days Payable	154	157	166	115	110	104	143	136
Cash Conversion Cycle	-56	-67	-68	44	86	41	-30	-30
Working Capital Days	-103	-172	-65	-43	21	-30	-59	-76
ROCE %	17%	17%	14%	13%	15%	13%	13%	10%

SYNGENEUpdated 16 Oct 2026, 12:10

Syngene International Ltd

SYNGENEUpdated 16 Oct 2026, 12:10

Market Cap

₹15,551Cr.

Current Price

₹385

High / Low

₹679/344

Stock P/E

51.8

ROE7.71%

ROCE9.91%

Book Value₹117

Face Value₹10.0

Dividend Yield0.33%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	715.8	6.1	552.4	22.9	88.7	91.5	17.7	75.3	1.87
Sep 2023	830.7	8.6	614.1	13.6	90.9	130.7	22.26	101.6	2.53
Dec 2023	791.9	6.3	592.4	25.1	93.6	124.7	19.97	99.8	2.48
Mar 2024	864.7	8.5	565.4	15.3	95.7	210.4	9.79	189.8	4.72
Jun 2024	726.5	7.4	578.3	49.7	91.7	98.8	25.2	73.9	1.84
Sep 2024	821.3	7	612.7	16.4	93.7	124.3	22.28	96.6	2.4
Dec 2024	877.1	6.7	626.3	18	92.3	169.8	27.5	123.1	3.06
Mar 2025	948.4	10.1	638.4	18.4	89.6	228.7	23.74	174.4	4.33
Jun 2025	799.3	5.9	631.2	16.6	94.6	84.2	12.11	74	1.84
Sep 2025	830.1	7.4	652.6	14.2	100.1	84.2	21.38	66.2	1.64
Dec 2025	834.4	6.2	649.7	-51.3	97.1	30.1	45.18	16.5	0.41
Mar 2026	960	6.5	675.7	14.2	95.3	196.7	24.66	148.2	3.68
Jun 2026	663	4.1	584.6	11.3	95.6	-10	-79	-2.1	-0.05

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	860	8	579	12	81	204	14	175	4.38
Mar 2016	1107	8	727	6	97	281	14	241	6.02
Mar 2017	1201	18	816	94	114	346	17	287	7.18
Mar 2018	1423	23	950	53	131	372	18	305	7.63
Mar 2019	1826	32	1290	75	164	414	20	331	8.27
Mar 2020	2012	35	1395	153	219	516	20	412	10.29
Mar 2021	2179	28	1504	94	274	467	14	404	10.09
Mar 2022	2601	24	1861	75	310	482	18	394	9.83
Mar 2023	3194	45	2252	63	359	601	21	473	11.78
Mar 2024	3203	30	2322	74	369	557	16	466	11.6
Mar 2025	3373	31	2453	100	367	622	25	468	11.63
Mar 2026	3424	26	2606	-9	387	395	23	305	7.57
TTM	3288	24	2563	-12	388	301	—	229	5.68

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	52.59%
FIIs	10.13%
DIIs	29.31%
Public	7.55%
Others	0.41%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public	Others
Dec 2023	54.79%	21.2%	14.63%	9.07%	0.32%
Mar 2024	54.79%	20.92%	15.8%	8.18%	0.31%
Jun 2024	54.72%	20.64%	16.78%	7.44%	0.43%
Sep 2024	54.72%	20.72%	17.49%	6.74%	0.34%
Dec 2024	52.74%	20.65%	19.52%	6.79%	0.29%
Mar 2025	52.74%	19.47%	21.5%	5.99%	0.29%
Jun 2025	52.68%	16.51%	24.05%	6.45%	0.31%
Sep 2025	52.68%	16.31%	24.62%	6.08%	0.3%
Dec 2025	52.68%	14.96%	25.83%	6.22%	0.29%
Mar 2026	52.68%	13.91%	26.44%	6.69%	0.29%
Jun 2026	52.59%	11.82%	28.01%	7.15%	0.43%
Sep 2026	52.59%	10.13%	29.31%	7.55%	0.41%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	199	646	155	422	1422	503	105	146	667	1422
Mar 2016	200	825	891	440	2356	580	237	277	1262	2356
Mar 2017	200	1213	806	555	2775	810	175	540	1249	2775
Mar 2018	200	1520	787	681	3188	1030	155	158	1845	3188
Mar 2019	200	1767	813	922	3702	1377	274	716	1336	3702
Mar 2020	400	1774	773	1215	4162	2020	234	777	1132	4162
Mar 2021	400	2418	893	1166	4878	2201	237	702	1737	4878
Mar 2022	401	2891	1022	1247	5561	2393	346	1034	1787	5561
Mar 2023	401	3218	639	1590	5848	2260	126	941	2521	5848
Mar 2024	402	3790	332	1310	5834	2318	760	928	1829	5834
Mar 2025	402	4236	306	1462	6407	2241	880	1468	1818	6407
Mar 2026	403	4301	201	1658	6563	2487	541	1564	1971	6563

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	18	16	-10	24
Mar 2016	308	-753	716	272
Mar 2017	398	-470	-81	-153
Mar 2018	446	-350	-79	17
Mar 2019	630	-646	-72	-88
Mar 2020	677	-424	-226	28
Mar 2021	698	-629	58	127
Mar 2022	582	-611	-31	-60
Mar 2023	838	-685	-340	-187
Mar 2024	913	-383	-536	-6
Mar 2025	1114	-810	-136	167
Mar 2026	831	-766	-178	-113

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	76	61	60	68	68	72	57	71	55	49	51	46
Inventory Days	59	44	37	82	30	18	41	87	141	95	62	60
Days Payable	106	87	116	194	154	157	166	115	110	104	143	136
Cash Conversion Cycle	29	18	-19	-44	-56	-67	-68	44	86	41	-30	-30
Working Capital Days	-64	-65	-44	-48	-103	-172	-65	-43	21	-30	-59	-76
ROCE %	23%	20%	18%	16%	17%	17%	14%	13%	15%	13%	13%	10%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SYNGENE INTERNATIONAL LTD (SYNGENE)?

The reported market capitalisation for SYNGENE INTERNATIONAL LTD (SYNGENE) is ₹15,551Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SYNGENE?

The current price shown for SYNGENE INTERNATIONAL LTD (SYNGENE) on Fincrux is ₹385 with a 52-week high/low of ₹679/344.

What is the P/E ratio of SYNGENE INTERNATIONAL LTD (SYNGENE)?

The stock P/E for SYNGENE INTERNATIONAL LTD (SYNGENE) is 51.8 on Fincrux, with ROE at 7.71% and ROCE at 9.91%.

What were SYNGENE latest quarterly results?

For Jun 2026, SYNGENE INTERNATIONAL LTD (SYNGENE) reported sales ₹663.00 Cr and net profit ₹-2.10 Cr (figures in ₹ crore unless noted).

What are SYNGENE annual sales and net profit?

For TTM, SYNGENE INTERNATIONAL LTD (SYNGENE) shows sales of ₹3,288 Cr and net profit of ₹229 Cr on the Fincrux profit & loss statement.

Who owns SYNGENE INTERNATIONAL LTD (SYNGENE)?

Latest shareholding for SYNGENE INTERNATIONAL LTD (SYNGENE) on Fincrux: Promoters 52.59% (Sep 2026), FIIs 10.13% (Sep 2026), DIIs 29.31% (Sep 2026), Public 7.55% (Sep 2026), Others 0.41% (Sep 2026).

Where can I find SYNGENE INTERNATIONAL LTD (SYNGENE) financials?

SYNGENE INTERNATIONAL LTD (SYNGENE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SYNGENE balance sheet and cash flow?

Yes. The SYNGENE INTERNATIONAL LTD (SYNGENE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 16 October 2026 at 12:10